{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:16:20Z","timestamp":1760242580304},"reference-count":21,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2012]]},"DOI":"10.3960\/jslrt.52.211","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T01:51:49Z","timestamp":1356141109000},"page":"211-218","source":"Crossref","is-referenced-by-count":11,"title":["Epstein-Barr Virus-Negative, CD5-Positive Diffuse Large B-Cell Lymphoma Developing after Treatment with Oral Tacrolimus for Mixed Connective Tissue Disease : A Case Report and Review of the Literature"],"prefix":"10.3960","volume":"52","author":[{"given":"Yasunobu","family":"Sekiguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsumi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Gaulard P, Swerdlow SH, Haris NL, Jaffe ES, Sundstrom C: Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In : Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, <I>et al<\/I>. (eds): World Health Organization Classification of Tumours, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, International Agency for Research on Cancer (IARC), pp.350-351, 2008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Fonacier L, Charlesworth EN, Spergel JM, Leung DY: The black box warning for topical calcineurin inhibitors : looking outside the box. Ann Allergy Asthma Immunol 97:117-120, 2006","DOI":"10.1016\/S1081-1206(10)61381-6"},{"key":"3","unstructured":"3 Information for Healthcare Professionals: Tacrolimus (marketed as Protopic) [http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm126497.htm]"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Dharnidharka VR, Sullivan EK, Stablein DM, Tejani AH, Harmon WE, North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation : a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 71:1065-1068, 2001","DOI":"10.1097\/00007890-200104270-00010"},{"key":"5","unstructured":"5 Younes BS, McDiarmid SV, Martin MG, Vargas JH, Goss JA, <I>et al<\/I>.: The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation 70:94-99, 2000"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Ellis D, Jaffe R, Green M, Janosky JJ, Lombardozzi-Lane S, <I>et al<\/I>.: Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. Transplantation 68:997-1003, 1999","DOI":"10.1097\/00007890-199910150-00017"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, Lennette ET, Martinez OM, <I>et al<\/I>.: An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 59:524-529, 1995","DOI":"10.1097\/00007890-199559040-00015"},{"key":"8","unstructured":"8 Thompson J, Weisner R, Lake J: Are tacrolimus (TAC) vs. cyclosporine ME (CSA)-based immunosuppressive regimens associated with different risks of death due to malignancy in adult liver transplant recipients ? Am J Transplant 7 (Suppl 2):466, 2007 (<I>Abstract<\/I>)"},{"key":"9","unstructured":"9 Pleasant L, Skinner S, Pulliam J, Challa H, D'Orazio J: Burkitt lymphoma in a child with atopic dermatitis and a 7-year history of regular topical tacrolimus use. Cutis 89:117-120, 2012"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, <I>et al<\/I>.: Association between exposure to topical tacrolimus or pimecrolimus and cancers. Ann Pharmacother 43:1956-1963, 2009","DOI":"10.1345\/aph.1M278"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Tennis P, Gelfand JM, Rothman KJ: Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. Br J Dermatol 165:465-473, 2011","DOI":"10.1111\/j.1365-2133.2011.10363.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Tha&#231;i D, Salgo R: Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis : facts and controversies. Clin Dermatol 28:52-56, 2010","DOI":"10.1016\/j.clindermatol.2009.04.001"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Arellano FM, Arana A, Wentworth CE, Fern&aacute;ndez-Vidaurre C, Schlienger RG, <I>et al<\/I>.: Lymphoma among patients with atopic dermatitis and\/or treated with topical immunosuppressants in the United Kingdom. J Allergy Clin Immunol 123:1111-1116, 2009","DOI":"10.1016\/j.jaci.2009.02.028"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1159\/000209289"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Arellano FM, Wentworth CE, Arana A, Fern&aacute;ndez C, Paul CF: Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol 127:808-816, 2007","DOI":"10.1038\/sj.jid.5700622"},{"key":"16","unstructured":"16 Rallis E, Economidi A, Verros C, Papadakis P: Successful treatment of patch type mycosis fungoides with tacrolimus ointment 0.1%. J Drugs Dermatol 5:906-907, 2006"},{"key":"17","unstructured":"17 Arai S, Yoshimi A, Iijima K, Iki S, Usuki K, <I>et al<\/I>.: Cutaneous lesions of angioimmunoblastic T-cell lymphoma successfully treated with tacrolimus. Rinsho Ketsueki 46:543-544, 2005 (<I>Abstract<\/I> <I>in English<\/I>)"},{"key":"18","unstructured":"18 Miseki T, Sugata H, Kubo Y, Shimaoka S, Sakai T, <I>et al<\/I>.: A case in which RA was not exacerbated during rituximab treatment of BL that occurred during FK506 use. Nihon Gan Chiryo Gakkai Shi 45:966, 2010 (<I>Abstract<\/I> <I>in English<\/I>)"},{"key":"19","unstructured":"19 Minami N, Fujiki N, Doi S, Kikuchi S, Shima K, <I>et al<\/I>.: A case of myasthenia gravis in which a variety of tumors developed during the clinical course. Neurol Therap 24:360, 2007 (<I>Abstract<\/I> <I>in English<\/I>)"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq627"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12810"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:46:11Z","timestamp":1621539971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/52\/3\/52_211\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.52.211","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}